| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.16 | 0.0002 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0003 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.19 | 0.0005 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0007 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0008 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.1 | 0.001 |